Literature DB >> 10644722

An artificial gene for human porphobilinogen synthase allows comparison of an allelic variation implicated in susceptibility to lead poisoning.

E K Jaffe1, M Volin, C R Bronson-Mullins, R L Dunbrack, J Kervinen, J Martins, J F Quinlan, M H Sazinsky, E M Steinhouse, A T Yeung.   

Abstract

Porphobilinogen synthase (PBGS) is an ancient enzyme essential to tetrapyrrole biosynthesis (e.g. heme, chlorophyll, and vitamin B(12)). Two common alleles encoding human PBGS, K59 and N59, have been correlated with differential susceptibility of humans to lead poisoning. However, a model for human PBGS based on homologous crystal structures shows the location of the allelic variation to be distant from the active site with its two Zn(II). Previous microbial expression systems for human PBGS have resulted in a poor yield. Here, an artificial gene encoding human PBGS was constructed by recursive polymerase chain reaction from synthetic oligonucleotides to rectify this problem. The artificial gene was made to resemble the highly expressed homologous Escherichia coli hemB gene and to remove rare codons that can confound heterologous protein expression in E. coli. We have expressed and purified recombinant human PBGS variants K59 and N59 in 100-mg quantities. Both human PBGS proteins purified with eight Zn(II)/octamer; Zn(II) binding was shown to be pH-dependent; and Pb(II) could displace some of the Zn(II). However, there was no differential displacement of Zn(II) by Pb(II) between K59 and N59, and simple Pb(II) inhibition studies revealed no allelic difference.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644722     DOI: 10.1074/jbc.275.4.2619

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  ALAD porphyria is a conformational disease.

Authors:  Eileen K Jaffe; Linda Stith
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

2.  Combinatorial Domain Hunting: An effective approach for the identification of soluble protein domains adaptable to high-throughput applications.

Authors:  Stefanie Reich; Loretto H Puckey; Caroline L Cheetham; Richard Harris; Ammar A E Ali; Uma Bhattacharyya; Kate Maclagan; Keith A Powell; Chrisostomos Prodromou; Laurence H Pearl; Paul C Driscoll; Renos Savva
Journal:  Protein Sci       Date:  2006-10       Impact factor: 6.725

Review 3.  Allostery and the dynamic oligomerization of porphobilinogen synthase.

Authors:  Eileen K Jaffe; Sarah H Lawrence
Journal:  Arch Biochem Biophys       Date:  2011-10-19       Impact factor: 4.013

4.  The activation mechanism of human porphobilinogen synthase by 2-mercaptoethanol: intrasubunit transfer of a reserve zinc ion and coordination with three cysteines in the active center.

Authors:  Nori Sawada; Noriyuki Nagahara; Tadashi Sakai; Yoshiaki Nakajima; Masayasu Minami; Tomoyuki Kawada
Journal:  J Biol Inorg Chem       Date:  2005-03-04       Impact factor: 3.358

5.  Lead burden and psychiatric symptoms and the modifying influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism: the VA Normative Aging Study.

Authors:  Pradeep Rajan; Karl T Kelsey; Joel D Schwartz; David C Bellinger; Jennifer Weuve; David Sparrow; Avron Spiro; Thomas J Smith; Huiling Nie; Howard Hu; Robert O Wright
Journal:  Am J Epidemiol       Date:  2007-09-06       Impact factor: 4.897

6.  Interaction of the delta-aminolevulinic acid dehydratase polymorphism and lead burden on cognitive function: the VA normative aging study.

Authors:  Pradeep Rajan; Karl T Kelsey; Joel D Schwartz; David C Bellinger; Jennifer Weuve; Avron Spiro; David Sparrow; Thomas J Smith; Huiling Nie; Marc G Weisskopf; Howard Hu; Robert O Wright
Journal:  J Occup Environ Med       Date:  2008-09       Impact factor: 2.162

7.  Thermodynamically balanced inside-out (TBIO) PCR-based gene synthesis: a novel method of primer design for high-fidelity assembly of longer gene sequences.

Authors:  Xinxin Gao; Peggy Yo; Andrew Keith; Timothy J Ragan; Thomas K Harris
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.